🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

!!!!!!!!! SO pumped for our Match!!!!!! This is the first year I won’t have overlap with our matched class (the curse of advanced specialties). Duke Radonc has such a special place in my heart and I’m so excited to invite you to the family 🥰 See you at ASTRO?? ☢️ Go Duke 😈🐂💙

Let me just take a moment to brag about Michael—one of the best medical students I’ve ever met (no exaggeration), heart of gold, stellar researcher, amazing communicator. Going to make the best radiation oncologist ever. I am so incredibly proud of him :) I’ll visit you in NY!

Anu!!!! What an amazing human! We are so lucky to have you at Duke 💙 reminds me of my own match day 🥹 I wish you could start in July rather than in a year 😭

I made the mistake of posting this the morning of match day originally, but give it a read before the free link expires! It’s a great trial—with an even greater ILROG confirmatory trial in the works ILROG Team IJROBP - The Red Journal ASTRO

Thank you JAMA Oncology for the opportunity to publish our global effort! 🌎🌍🌏 I am so grateful to our team: Drs James Wu | 吴简凡 MD @Erin_Feliciano @FredTingMD @Jonas_Willmann @FrancesVHo Bhav Jain UrvishJain @JennyCh7799 @FabioMoraesMD @IMRTLee Puneeth Iyengar Paul Nguyen 🙏

Congratulations to our #MedPhys resident matches for 2025! We're so excited to welcome Lam and Chenlu to the Duke Cancer #RadOnc team this year 💙 #MedPhysMatch Duke Medical Physics

That's my coresident :)

That’s my mentor :)

“Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib should be considered a new standard of care for Stage IV BRAF V600E-mutated anaplastic thyroid cancer,” says our Mark Zafereo, MD at #ASCO25. Read more about this practice-changing research:

Practice changing study in anaplastic thyroid cancer! Proud to have contributed to the study. This is an aggressive, rare, and difficult to treat cancer and we are moving the needle! Huge shout out to our clinical trials teams. Mark Zafereo, MD MD Anderson Cancer Center Huntsman Cancer Institute

Thanks for leading this important study and letting Duke Radiation Oncology Duke Cancer Network Duke University be a part of it 💪

My PD! Best one ever tbh.

Radiation therapy—specifically external beam + brachytherapy boost cures patients with cervical cancer. This is the standard! It’s a team sport, so don’t forget any members of the team! 💪

Standing room only for Nikhil Mankuzhy, MD oral on PET-response adapted 4 Gy for potentially curable indolent lymphomas! Great job pushing the frontier of RT! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center ILROG Team #18ICML

Double trouble! Congrats to Rosh on his important work showing that bridging RT prior to CAR T cells is safe and probably needs greater personalization by tumor genetics. Great work! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center #18ICML

Congrats to Alok Deshane on his #18ICML poster seeking to modernize our understanding of which mantle cell lymphoma patients benefit from radiotherapy💥💥Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center

She’s✨amazing✨

I'll never forget the stories of John and Lauren at the American Brachy conference. We do it for our patients, and sometimes our patients are superstars who are bravely vulnerable and tell their stories to help others. Brachytherapy Cures Cancer.

Follow me on blue sky! bsky.app/profile/chrhua… Meded 📚and brachytherapy ☢️ content galore (eventually)